🟢 Intravenous Infusions is trading 7.5% up today

Intravenous Infusions is trading at GHS 0.43, up +7.50%, with no clear company-specific announcement identified for the August 17, 2026 rebound.

• The move follows heavy profit-taking after the speculative July 30 rally to GHS 0.86, which drove declines through August 12.
• A board appointment reported roughly 11 days earlier appears stale and does not establish today’s catalyst.
• Broader markets are mixed, offering no clear global explanation for the gain.